Corey M. Ohnmacht

Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography.

D. S. Hage, Jianzhong Chen, Corey M. Ohnmacht, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.

John E. Schiel, D. S. Hage, Corey M. Ohnmacht, 2009, Analytical chemistry.

Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin.

D. S. Hage, Corey M. Ohnmacht, Zenghan Tong, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Analysis of free drug fractions using near-infrared fluorescent labels and an ultrafast immunoextraction/displacement assay.

John E. Schiel, D. S. Hage, Corey M. Ohnmacht, 2006, Analytical chemistry.

Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns.

John E. Schiel, D. S. Hage, Q. Smith, 2011, Journal of chromatography. A.

Characterization of drug interactions with soluble beta-cyclodextrin by high-performance affinity chromatography.

D. S. Hage, Jianzhong Chen, Corey M. Ohnmacht, 2004, Journal of chromatography. A.

Assay development for determination of tenofovir in human plasma by solid phase analytical derivatization and LC-MS/MS.

A. Podany, Corey M. Ohnmacht, Daryl D. Grafelman, 2015, Bioanalysis.

Sample stabilization strategies: a case study review of unique sample collection and handling procedures.

Vishal Patel, Corey Ohnmacht, Megan Cooley, 2019, Bioanalysis.

Very complex internal standard response variation in LC-MS/MS bioanalysis: root cause analysis and impact assessment.

N. C. van de Merbel, R. Koster, Corey M. Ohnmacht, 2019, Bioanalysis.

LC‐MS Bioanalysis of Photosensitive and Oxidatively Labile Compounds

Corey M. Ohnmacht, 2013 .